Holen Sie sich die Stockscreener-App
71.30
2.76%
-2.02
Schlusskurs vom Vortag:
$73.32
Offen:
$73.33
24-Stunden-Volumen:
105.06K
Relative Volume:
0.64
Marktkapitalisierung:
$788.55M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-2.52%
1M Leistung:
+25.77%
6M Leistung:
+168.45%
1J Leistung:
+0.00%
1-Tages-Spanne:
$70.55
$75.52
1-Wochen-Bereich:
$70.55
$77.77
52-Wochen-Spanne:
$11.17
$77.77
Palvella Therapeutics Inc Stock (PVLA) Company Profile
Firmenname
Palvella Therapeutics Inc
Sektor
Branche
Telefon
(484) 253-1461
Adresse
125 STRAFFORD AVE, WAYNE
Vergleichen Sie PVLA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PVLA
Palvella Therapeutics Inc
|
71.30 | 836.72M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
422.63 | 109.29B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.00 | 62.13B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
575.69 | 61.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.18 | 51.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
310.03 | 34.68B | 4.56B | -176.77M | 225.30M | -1.7177 |
Palvella Therapeutics Inc Stock (PVLA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-09 | Eingeleitet | Oppenheimer | Outperform |
| 2025-08-06 | Eingeleitet | Raymond James | Outperform |
| 2025-07-21 | Eingeleitet | Truist | Buy |
| 2025-04-09 | Eingeleitet | Chardan Capital Markets | Buy |
| 2025-03-26 | Eingeleitet | Stifel | Buy |
| 2025-03-07 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-02-20 | Eingeleitet | Canaccord Genuity | Buy |
| 2025-02-05 | Eingeleitet | TD Cowen | Buy |
| 2024-12-26 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-12-18 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-03-13 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-07-30 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-05-14 | Eingeleitet | Robert W. Baird | Outperform |
| 2018-03-19 | Eingeleitet | Evercore ISI | Outperform |
| 2018-03-19 | Eingeleitet | Jefferies | Buy |
| 2018-01-16 | Bestätigt | H.C. Wainwright | Buy |
| 2017-05-30 | Eingeleitet | Rodman & Renshaw | Buy |
| 2016-08-05 | Fortgesetzt | ROTH Capital | Buy |
| 2015-08-12 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2015-07-27 | Eingeleitet | Oppenheimer | Outperform |
| 2015-07-22 | Eingeleitet | ROTH Capital | Buy |
Alle ansehen
Palvella Therapeutics Inc Aktie (PVLA) Neueste Nachrichten
Can Palvella Therapeutics Inc. stock rebound after recent weaknessQuarterly Market Summary & Weekly Chart Analysis and Trade Guides - newser.com
Can Palvella Therapeutics Inc. stock maintain growth trajectoryInsider Buying & Long-Term Capital Growth Strategies - newser.com
Multi factor analysis applied to Palvella Therapeutics Inc.Quarterly Profit Review & Target Return Focused Stock Picks - newser.com
Will a bounce in Palvella Therapeutics Inc. offer an exitWeekly Market Report & Weekly High Conviction Trade Ideas - newser.com
Trend analysis for Palvella Therapeutics Inc. this weekQuarterly Profit Review & Low Risk High Win Rate Stock Picks - newser.com
Is Palvella Therapeutics Inc. (PI6) stock a good hedge against inflationMarket Activity Recap & Free Fast Gain Swing Trade Alerts - newser.com
How Palvella Therapeutics Inc. stock performs in stagflationQuarterly Portfolio Report & Fast Momentum Entry Tips - newser.com
Tools to monitor Palvella Therapeutics Inc. recovery probabilityJuly 2025 Sentiment & Accurate Buy Signal Notifications - newser.com
Why Palvella Therapeutics Inc. (PI6) stock is favored by hedge funds2025 Market Overview & Fast Moving Stock Trade Plans - newser.com
Can Palvella Therapeutics Inc. stock withstand economic slowdownJuly 2025 Institutional & Stepwise Swing Trade Plans - newser.com
How institutional ownership impacts Palvella Therapeutics Inc. stockJuly 2025 Trade Ideas & Safe Swing Trade Setup Alerts - newser.com
Published on: 2025-10-21 16:43:34 - newser.com
Real time social sentiment graph for Palvella Therapeutics Inc.Weekly Stock Analysis & Community Consensus Picks - newser.com
Is Palvella Therapeutics Inc. meeting your algorithmic filter criteriaQuarterly Earnings Summary & Detailed Earnings Play Strategies - newser.com
Published on: 2025-10-21 06:40:39 - newser.com
What MACD and RSI say about Palvella Therapeutics Inc.Analyst Upgrade & Risk Controlled Daily Trade Plans - newser.com
Palvella Therapeutics Receives Second Year of FDA Grant Funding for Phase 3 SELVA Trial - MyChesCo
Published on: 2025-10-20 19:30:03 - newser.com
Why global investors buy Palvella Therapeutics Inc. (PI6) stockQuarterly Portfolio Review & Verified Technical Signals - newser.com
Reversal indicators forming on Palvella Therapeutics Inc. stockWeekly Gains Summary & Detailed Earnings Play Strategies - newser.com
Earnings Recap: Is Palvella Therapeutics Inc. (PI6) stock a contrarian opportunity2025 Key Lessons & Precise Buy Zone Tips - nchmf.gov.vn
Ideas Watch: Will Palvella Therapeutics Inc. stock outperform value stocks2025 Technical Patterns & Daily Growth Stock Tips - nchmf.gov.vn
Finanzdaten der Palvella Therapeutics Inc-Aktie (PVLA)
Es liegen keine Finanzdaten für Palvella Therapeutics Inc (PVLA) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.03%
0.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):